Ronald Silver - Aug 12, 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Principal Accounting Officer
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Aug 12, 2024
Transactions value $
-$13,267
Form type
4
Date filed
8/14/2024, 05:08 PM
Previous filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale -$13.3K -3.11K -1.92% $4.27 158K Aug 12, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.